Back
Speaker illustration

undefined undefined undefined

Presentations Articles

CYP2C19 genetic variants and coronary atherosclerosis: insights beyond antiplatelet therapy

Event: ESC Congress 2025

Topic: Thrombosis, Platelets, and Coagulation

Session: Antithrombotic therapy in acute coronary syndromes

Access
Like
Thumbnail

Routine oral glucose tolerance test to improve risk stratification in acute coronary syndrome patients

Event: ESC Congress 2025

Topic: Prevention

Session: Biomarkers and assessing outcomes in coronary artery disease

Access
Like
Thumbnail

Undiagnosed impaired glucose tolerance/diabetes mellitus and relationship with aortic stiffness in patients with acute coronary syndromes

Event: ESC Congress 2024

Topic: Prevention

Session: Risk factors and characterisation of coronary artery disease

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources